Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neuroendocrine Tumors 3Lung Neoplasms 3Breast Neoplasms 3Respiratory Insufficiency 1Radiation Pneumonitis 1Prostatic Neoplasms 1Parkinson Disease 1Lymphoma, Non-Hodgkin 1Lung Diseases 1Hodgkin Disease 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Abnormalities, Radiation-Induced 1

Interventions

Rituximab 344Cyclophosphamide 317fludarabine phosphate 142Etoposide 139Peripheral Blood Stem Cell Transplantation 124fludarabine 112Filgrastim 112Mycophenolic Acid 98Melphalan 98Whole-Body Irradiation 90Vincristine 90Busulfan 87Cytarabine 85Doxorubicin 79Cyclosporine 76Tacrolimus 75Radiotherapy 75Prednisone 73Bendamustine Hydrochloride 72Granulocyte Colony-Stimulating Factor 66Methotrexate 65Antilymphocyte Serum 56Carmustine 54Dexamethasone 50Gemcitabine 48Lenalidomide 46Bortezomib 43venetoclax 41ibritumomab tiuxetan 37obinutuzumab 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Non-Hodgkin × Tomography, Emission-Computed, Single-Photon × Clear all
NCT04292626 2021-04-01

Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed
16 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡